Chonluten

Research Overview

Chonluten serves as a research tool for investigating respiratory system-specific bioregulation and bronchial tissue function in laboratory settings. This peptide bioregulator is a defined synthetic Glu-Asp-Gly (EDG) tripeptide, also designated T-34, belonging to the class of Khavinson short peptides originally developed through research on tissue-specific regulatory mechanisms. Respiratory bioregulator research complements studies using Livagen for hepatic tissue regulation and Ovagen for gastric mucosa function within the Khavinson bioregulator framework. The bioregulator concept proposes that short peptides corresponding to specific organs act as information molecules that can influence cellular function in corresponding target tissues.

Chonluten research applications extend across multiple areas of respiratory biology including bronchial epithelial cell function, airway mucosa barrier regulation, mucociliary clearance mechanisms, lung-immune interactions, and respiratory system aging processes. Laboratory protocols examine these effects in cell culture systems, bronchial tissue explants, and preclinical animal models to understand respiratory tissue regulation at molecular and cellular levels.

The peptide’s defined synthetic identity provides research interest in tissue selectivity and targeted cellular regulation. Studies investigate how the EDG tripeptide interacts with bronchial epithelial cells, the mechanisms underlying tissue-specific effects, and potential applications in understanding respiratory function and lung system biology. Research models include bronchial epithelial cell cultures, airway organoid systems, and various epithelial barrier assessment protocols.

Molecular Characteristics

Defined Composition:

• Classification: Synthetic peptide bioregulator (Khavinson short peptide)
• Source/Origin: Synthetic (solid-phase peptide synthesis)
• Amino Acid Sequence: Glu-Asp-Gly (EDG)
• Molecular Formula: C₁₁H₁₇N₃O₈
• Molecular Weight: 319.27 Da
• CAS Number: 75007-24-8
• Form: White to off-white lyophilized powder
• Solubility: Water, phosphate buffered saline, cell culture media

Chonluten is a single, defined molecular entity: the synthetic tripeptide Glu-Asp-Gly (EDG). It consists of one precisely characterized sequence, enabling reproducible research models and clear structure-function interpretation. This defined composition reflects modern solid-phase peptide synthesis methodology, in which the sequence is assembled and purified to a consistent, well-defined product while maintaining a reproducible activity profile.

The tripeptide’s compact size (319.27 Da, three amino acid residues) places it firmly within the Khavinson short-peptide class. Such short peptides are theorized to serve as information molecules, carrying tissue-specific regulatory signals that influence gene expression and cellular function in target tissues.

Bioregulator Peptide Research Background

Chonluten belongs to the research category of short regulatory peptides (cytomaxes/cytogens) developed to investigate tissue-specific cellular regulation. This research approach emerged from studies on how peptide signals influence cellular differentiation, function, and tissue homeostasis. The bioregulator hypothesis proposes that:

1. Organs are associated with specific peptide signals that regulate cellular function
2. Short peptides corresponding to specific tissues demonstrate selective affinity for corresponding organs
3. These peptides may influence gene expression and protein synthesis in target cells
4. Bioregulator effects occur through interaction with cellular regulatory mechanisms

Research on respiratory system bioregulators like Chonluten investigates these mechanisms in bronchial and lung tissue contexts, examining how peptide signals might modulate bronchial epithelial function, airway barrier integrity processes, and respiratory tissue homeostasis in experimental models.

Research Applications

Bronchial Epithelial Cell Research

Chonluten serves as a research tool for investigating bronchial epithelium function and regulation:

• Epithelial Cell Proliferation: Investigation of basal cell division, progenitor cell expansion, and airway epithelial renewal rates
• Cell Differentiation Studies: Research on ciliated cell, goblet cell, club (Clara) cell, and basal cell differentiation pathways
• Airway Architecture Research: Examination of epithelial layer thickness, pseudostratified organization, and bronchial wall structure
• Gene Expression Studies: Investigation of airway epithelium-specific genes including ciliogenesis factors, junction proteins, and mucin genes
• Stem Cell Regulation: Research on airway basal stem cell maintenance and lineage specification

Laboratory protocols employ bronchial epithelial cell cultures (BEAS-2B, 16HBE, NHBE), primary airway epithelial cultures, and air-liquid interface organoid systems to characterize Chonluten effects on epithelial cell function.

Airway Barrier Function Research

Research applications extend to airway barrier integrity and regulation:

• Tight Junction Studies: Investigation of tight junction protein expression (claudins, occludin, ZO proteins) and barrier assembly
• Permeability Regulation: Examination of transcellular and paracellular permeability in airway epithelial models
• Airway Surface Liquid Research: Studies on mucin production, mucus layer thickness, and protective function
• Epithelial Defense Mechanisms: Investigation of antimicrobial peptide production (defensins, cathelicidins) in the airway
• Barrier Repair Studies: Research on epithelial wound healing and barrier restoration after airway injury

Experimental approaches include transepithelial electrical resistance (TEER) measurements, permeability assays, and immunofluorescence analysis of junction proteins to understand barrier function regulation.

Mucociliary and Surfactant Function Studies

Laboratory studies investigate Chonluten in airway clearance and surfactant contexts:

• Mucociliary Clearance Research: Examination of ciliary beat frequency, coordinated metachronal motion, and particle transport
• Mucin Secretion Studies: Investigation of MUC5AC and MUC5B expression, goblet cell secretion, and mucus rheology
• Surfactant Investigation: Research on pulmonary surfactant protein expression (SP-A, SP-B, SP-C, SP-D) and lipid components
• Ion Transport Research: Studies on epithelial sodium and chloride channel activity governing airway surface hydration
• Ciliogenesis Studies: Examination of basal body docking, axoneme assembly, and ciliated cell maturation

Research protocols examine how short bioregulator peptides might influence ciliary function, mucin expression, and surfactant production in airway cell models.

Lung Immune Function Research

Chonluten research applications include respiratory immunity investigation:

• Innate Immunity Studies: Research on airway epithelial pattern recognition receptors (TLRs, NODs) and immune responses
• Cytokine Production Research: Examination of inflammatory and anti-inflammatory cytokine expression in airway cells
• Immune Cell Interaction Studies: Investigation of epithelial-immune cell communication (alveolar macrophages, dendritic cells, T cells)
• Tolerance Mechanisms: Research on airway tolerance, regulatory T cell induction, and anti-inflammatory responses
• Microbiome Interaction Studies: Examination of host-microbe communication and respiratory commensal recognition

Research approaches include co-culture models of epithelial and immune cells, cytokine profiling, and pathogen stimulation assays to understand lung immune regulation.

Respiratory Aging Research

Chonluten serves as a tool for investigating age-related changes in respiratory tissue:

• Cellular Senescence Studies: Examination of aging markers in bronchial epithelium and supporting cells
• Regenerative Capacity Research: Investigation of age-related decline in airway stem cell function and epithelial renewal
• Barrier Function Changes: Studies on aging-associated increases in airway epithelial permeability
• Mucociliary Efficiency Decline: Research on reduced ciliary function and clearance capacity with aging
• Oxidative Stress Accumulation: Analysis of reactive oxygen species and oxidative damage in aging lung tissue

Research protocols employ aging models, senescence-associated marker analysis, and comparative studies across different age groups in experimental systems.

Airway Organoid Research

Laboratory studies examine Chonluten effects in 3D respiratory models:

• Organoid Formation Studies: Investigation of bronchosphere budding, lumen formation, and airway organoid architecture
• Stem Cell Niche Research: Examination of basal stem cell maintenance and supporting cell interactions in organoids
• Organoid Differentiation: Studies on ciliated and secretory cell specification and maturation in 3D culture
• Functional Assays: Research on organoid barrier function, ciliary activity, and ion transport mechanisms
• Disease Modeling: Investigation of injury, inflammation, and repair processes in airway organoid systems

Experimental models include bronchial and alveolar organoids from various species, enabling physiologically relevant tissue-level studies.

Laboratory Handling and Storage Protocols

Lyophilized Powder Storage:

• Store at 2-8°C (refrigerated) in original sealed vial
• Protect from light exposure and moisture
• Do not freeze lyophilized powder
• Stable for 24 months refrigerated as unopened vial
• Record receipt date for laboratory inventory

Handling Precautions:
Short peptide preparations require careful handling to maintain activity:

• Use sterile technique for cell culture applications
• Avoid prolonged exposure to room temperature
• Minimize exposure to direct light
• Use appropriate peptide-compatible labware (low-binding tubes)
• Follow standard laboratory peptide handling protocols

Quality Assurance and Analytical Testing

Each Chonluten batch undergoes characterization appropriate for a defined synthetic peptide:

Identity and Purity Analysis:

• High-Performance Liquid Chromatography (HPLC): Purity ≥98% by area
• Mass spectrometry: Identity confirmed by ESI-MS at 319.27 Da
• Amino acid analysis: Confirms Glu-Asp-Gly composition
• Peptide content determination: Quantifies net peptide content by weight

Purity Testing:

• Chromatographic purity: ≥98% single-peak by analytical HPLC
• Related substances: Synthesis-related impurities below specified limits
• Counterion content: Trifluoroacetate or acetate within specified range
• Heavy metals: Below detection limits per pharmacopeia standards

Contaminant Testing:

• Bacterial endotoxin: <10 EU/mg (LAL method)
• Sterility testing: Sterile filtration and microbiological testing
• Residual solvents: Within acceptable limits
• Water content: Karl Fischer titration (<8%)

Synthesis and Identity Verification:

• Origin: Defined synthetic peptide produced by solid-phase peptide synthesis
• Sequence confirmation: Glu-Asp-Gly (EDG) verified by MS/MS sequencing
• Processing validation: Standardized synthesis and purification protocols
• Batch-to-batch consistency: Quality control testing across production batches

Documentation:

• Certificate of Analysis (COA) with batch-specific data
• HPLC purity chromatogram
• Mass spectrometry identity report
• Quality control test results
• Lot number traceability

Research Considerations

Experimental Design Factors:

Researchers should consider several factors when designing experiments with Chonluten:

1. Concentration Selection: Short bioregulator peptide research typically employs concentrations ranging from 0.1-10 μg/mL in cell culture studies. Optimal concentration should be determined empirically for specific experimental systems.

2. Treatment Duration: Published research suggests effects may require 24-72 hours to manifest in cell culture models. Longer durations (5-14 days) often used for differentiation and maturation studies.

3. Cell Type Specificity: While designated as respiratory system-specific, tissue selectivity should be verified in each experimental system through comparative studies with other cell types.

4. Polarization Considerations: Airway epithelial cells require polarized culture conditions. Use air-liquid interface (Transwell) systems for barrier and mucociliary studies.

5. Defined Peptide Considerations: As a single, well-characterized tripeptide, observed effects can be attributed to one defined sequence, supporting clearer mechanistic interpretation.

Control Groups:

Appropriate controls for short bioregulator peptide research include:

• Vehicle control (vehicle buffer only)
• Non-specific peptide control (scrambled peptides or unrelated bioregulator)
• Positive controls where applicable (growth factors, barrier modulators)
• Tissue-specific comparisons (same peptide concentration in non-respiratory cells)

Mechanism Investigation:

Chonluten mechanisms remain active research areas. Investigated mechanisms include:

• Gene expression modulation through transcription factor regulation (NKX2-1, FOXJ1)
• Epigenetic modifications influencing airway gene expression
• Wnt signaling pathway regulation (important for airway stem cell maintenance)
• Growth factor receptor signaling (EGF, TGF-β)
• Tight junction protein regulation
• Direct nuclear effects on chromatin and gene regulation

Research approaches combine molecular biology techniques, genomic and proteomic analysis, barrier function assays, and organoid culture systems to elucidate bioregulator action mechanisms.

Compliance and Safety Information

Regulatory Status:
Chonluten is provided as a research chemical for in-vitro laboratory studies and preclinical research only. This synthetic peptide bioregulator has not been approved by the FDA for human therapeutic use, dietary supplementation, or medical applications.

Intended Use:

• In-vitro cell culture research
• Bronchial tissue explant studies
• Airway organoid culture research
• In-vivo preclinical research in approved animal models
• Laboratory investigation of respiratory tissue regulation
• Academic and institutional research applications

NOT Intended For:

• Human consumption or administration
• Therapeutic treatment or diagnosis
• Dietary supplementation
• Veterinary therapeutic applications without appropriate oversight
• Any medical or clinical applications

Safety Protocols:
Researchers should follow standard laboratory safety practices:

• Use appropriate personal protective equipment (lab coat, gloves, safety glasses)
• Handle in biosafety cabinet for sterile work
• Follow institutional biosafety guidelines
• Dispose of waste according to laboratory chemical waste protocols
• Consult material safety data sheet (MSDS) for additional information

Material Source Considerations:
Chonluten is a fully synthetic peptide with no animal-derived starting material. Researchers should:

• Follow institutional guidelines for handling synthetic research peptides
• Maintain records of certificate of analysis and lot documentation
• Apply appropriate biosafety practices for laboratory chemicals
• Verify identity against the supplied COA before experimental use

—